Search
forResearch 10 of 1000+
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- A novel AR molecular glue degrader via bivalent engagement of the N-terminal domain and RNF213–UBE2J2 complex
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- DEFINING THE ROLE OF ABI1 GENE IN PROSTATE CANCER PROGRESSION AND TREATMENT RESISTANCE
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- A Review: Pharmacological Activities of Quinoline Alkaloid of Cinchona sp.
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Physical and mechanical properties of the hair shaft: A review of measurement techniques to verify the efficacy of cosmetic products
- Virilización y enfermedad metabólica en mujer postmenopáusica relacionado a hiperplasia e hipertecosis ovárica
- La combinación de finasteride y doxazosina fue más efectiva que la monoterapia en la hiperplasia prostática benigna
Community 4 of 58
- AH-001 another topical AR degrader beside GT20029, completed Phase I
- Is there any role for topical DHT antagonists, or does a 5-AR inhibitor remove the need for them as therapy
- 1 year 5-ar. Blood test results
- Why does this industry still revolve around 5-AR inhibitors?
Learn
— no results
Try a deeper search in learn →